期刊文献+

UHRF2结构域突变体的原核表达与纯化

Prokaryotic Expression and Purification of Domain Based Mutants of UHRF2
原文传递
导出
摘要 目的构建UHRF2各个以结构域为基础的突变体原核表达载体,在大肠埃希菌中表达并对融合蛋白进行纯化和鉴定。方法以pCMV-3xFlag—UHRF2为模板,PCR扩增UHRF2的各个结构域基因片段,各PCR产物经酶切后连接到pGEX-4T-1载体上;将重组载体转化大肠埃希菌(BL21菌株),IPTG诱导表达各GST融合蛋白,超声波破碎细菌,离心收获蛋白并经谷胱甘肽琼脂糖凝胶4B(glutathione sepharose 4B)亲合纯化;纯化的蛋白经SDS-PAGE电泳后用考马斯亮蓝染色或免疫印记实验鉴定各蛋白表达情况。结果成功构建了UHRF2结构域突变体的原核表达载体,各突变体蛋白表达正确。结论UHRF2各结构域突变体的成功构建便于用GST pull—down实验研究UHRF2参与与其它蛋白相互作用的结构域,为了解UHRF2功能打下了基础。 Objective To construct domain-based GST (glutathione-S-transferase) fusion mu- tant expressing vectors of UHRF2, purify and verify all the prokaryotically expressed proteins for downstream purpose. Methods DNA fragments of each domain of UHRF2 were amplified by PCR method; the PCR products were digested with restriction enzymes and incorporated into pGEX-4T-1 vector. All established mutants were expressed in the transformed BL21 strain of E. coli by IPTG in- duction. The GST-fusion mutants containing bacteria were collected, sonicated and purified for the proteins using Glutathione Sepharose 4B. Purified proteins were subjected to SDS-PAGE followed by CBB staining or immunobloting assay. Results All the domain-based GST fusion mutants of UHRF2 were constructed successfully into prokaryotic expressing vectors and prokaryotically expressed prod- ucts were purified and confirmed. Conclusion The constructed domain-based mutants of UHRF2 can be used in GST pull-down assay to study UHRF2 domains that may be implicated in its partner association, thus enabling further understanding of UHRF2.
出处 《医学分子生物学杂志》 CAS CSCD 2012年第2期98-102,共5页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30872248),重庆市科技委员会资助(No.2008BB5400),重庆市教育委员会资助(No.KJ080326)
关键词 UHRF2 结构域突变体 GST融合蛋白 ICBP90 表观遗传学 UHRF2 domain-based mutants GST fusion proteins ICBP90 epigenetics
  • 相关文献

参考文献3

二级参考文献29

  • 1Pickart C M,Eddins M J.Ubiquitin:structures,functions,mechanisms.Biochim Biophys Acta,2004,1695 (1 ~3):55~72.
  • 2Smalle J,Vierstra R D.The ubiquitin 26 S proteasome proteolytic pathway.Annu Rev Plant Biol,2004,55:555 ~590.
  • 3Roos-Mattjus P,Sistonen L.The ubiquitin-proteasome pathway.Ann Med,2004,36 (4):285~295.
  • 4Joazeiro C A,Weissman A M.RING finger proteins:mediators of ubiquitin ligase activity.Cell,2000,102 (5):549~552.
  • 5Magae J,Illenye S,Tejima T,et al.Transcriptional squelching by ectopic expression of E2F-1 and p53 is alleviated by proteasome inhibitors MG-132 and lactacystin.Oncogene,1997,15 (7):759~769.
  • 6Robinson P A,Ardley H C.Ubiquitin-protein ligases.J Cell Sci,2004,117:5191~5194.
  • 7Li Y,Mori T,Hata H,et al.NIRF induces G1 arrest and associates with Cdk2.Biochem Biophys Res Commun,2004,319 (2):464 ~468.
  • 8Mori T,Li Y,Hata H,et al.NIRF,a novel RING finger protein,is involved in cell-cycle regulation.Biochem Biophys Res Commun,2002,296 (3):530~536.
  • 9Mori T,Li Y,Hata H,et al.NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP,a PEST-containing nuclear protein.FEBS Lett,2004,557 (1 ~3):209~214.
  • 10Moll U M,Petrenko O.The MDM2-p53 interaction.Mol Cancer Res,2003,1 (14):1001 ~1008.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部